Literature DB >> 25553227

Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine.

Mark J Burish1, Katie L Thoren2, Maura Madou1, Shahed Toossi1, Maulik Shah1.   

Abstract

Although traditional hallucinogenic drugs such as marijuana and lysergic acid diethylamide (LSD) are not typically associated with seizures, newer synthetic hallucinogenic drugs can provoke seizures. Here, we report the unexpected consequences of taking a street-bought hallucinogenic drug thought to be LSD. Our patient presented with hallucinations and agitation progressing to status epilepticus with a urine toxicology screen positive only for cannabinoids and opioids. Using liquid chromatography high-resolution mass spectrometry, an additional drug was found: an amphetamine-derived phenylethylamine called 2,5-dimethoxy-4-chloroamphetamine. We bring this to the attention of the neurologic community as there are a growing number of hallucinogenic street drugs that are negative on standard urine toxicology and cause effects that are unexpected for both the patient and the neurologist, including seizures.

Entities:  

Keywords:  epilepsy; neurochemistry; neuropharmacology; neurotoxicity syndromes; seizures; techniques

Year:  2015        PMID: 25553227      PMCID: PMC4272348          DOI: 10.1177/1941874414528939

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  11 in total

1.  Multiple MDMA (Ecstasy) overdoses at a rave event: a case series.

Authors:  Patil Armenian; Tanya M Mamantov; Ben T Tsutaoka; Roy R L Gerona; Eric F Silman; Alan H B Wu; Kent R Olson
Journal:  J Intensive Care Med       Date:  2012-05-28       Impact factor: 3.510

2.  Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry.

Authors:  Andreas H Ewald; Dorothea Ehlers; Hans H Maurer
Journal:  Anal Bioanal Chem       Date:  2008-02-08       Impact factor: 4.142

Review 3.  Bath salts.

Authors:  Roy R Gerona; Alan H B Wu
Journal:  Clin Lab Med       Date:  2012-09       Impact factor: 1.935

4.  First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening.

Authors:  Hanna Ovaska; Adie Viljoen; Malgorzata Puchnarewicz; Jenny Button; John Ramsey; David W Holt; Paul I Dargan; David M Wood
Journal:  Eur J Emerg Med       Date:  2008-12       Impact factor: 2.799

5.  Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays.

Authors:  M Petrie; K L Lynch; S Ekins; J S Chang; R J Goetz; A H B Wu; M D Krasowski
Journal:  Clin Toxicol (Phila)       Date:  2013-02       Impact factor: 4.467

Review 6.  Hallucinogens.

Authors:  David E Nichols
Journal:  Pharmacol Ther       Date:  2004-02       Impact factor: 12.310

7.  2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.

Authors:  Andreas H Ewald; Hans H Maurer
Journal:  Toxicol Lett       Date:  2008-09-30       Impact factor: 4.372

8.  The secret "spice": an undetectable toxic cause of seizure.

Authors:  Adam de Havenon; Brian Chin; Karen C Thomas; Pegah Afra
Journal:  Neurohospitalist       Date:  2011-10

9.  Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures.

Authors: 
Journal:  Pediatrics       Date:  2008-06       Impact factor: 7.124

Review 10.  Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention.

Authors:  John Paul Leach; Rajiv Mohanraj; William Borland
Journal:  Epilepsia       Date:  2012-09       Impact factor: 5.864

View more
  5 in total

1.  Proposed Confidence Scale and ID Score in the Identification of Known-Unknown Compounds Using High Resolution MS Data.

Authors:  Bertrand Rochat
Journal:  J Am Soc Mass Spectrom       Date:  2017-01-23       Impact factor: 3.109

2.  Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports.

Authors:  Michal Ordak; Aleksandra Zmysłowska; Miłosz Bielski; Daniel Rybak; Maja Tomaszewska; Katarzyna Wyszomierska; Aleksandra Kmiec; Natalia Garlicka; Maria Zalewska; Michal Zalewski; Tadeusz Nasierowski; Elzbieta Muszynska; Magdalena Bujalska-Zadrozny
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

Review 3.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

Review 4.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

5.  Comparative therapeutic index, lethal time and safety margin of various toxicants and snake antivenoms using newly derived and old formulas.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  BMC Res Notes       Date:  2020-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.